Organic compounds -- part of the class 532-570 series inventions 08/09

20090216018 - Organometallic complexes: Organometallic complexes are provided, methods for making the same, and their use in devices and sub-assemblies.... Agent: Woodcock Washburn LLP

20090216019 - Process for production of optically active quinuclidinols: A novel ruthenium complex which is a highly efficient catalyst useful for the production of optically active 3-quinuclidinols, and a process for production of optically active 3-quinuclidinols using the ruthenium complex as a catalyst, where the optically active 3-quinuclidinols are useful as an optically active, physiologically active compound utilized in... Agent: Wolf Greenfield & Sacks, P.c.

20090216020 - Emission material and organic electroluminescent device using the same: n

20090216021 - Photosensitizer dye: A theme of the present invention is to provide a new transition metal complex, useful as a photosensitizer dye for a photoelectric conversion element having an excellent durability and a high photoelectric conversion characteristic. The present invention provides a bivalent transition metal complex constituted of (i) a bipyridyl polyacidic ligand,... Agent: Oliff & Berridge, Plc

20090216022 - Cyclopamine analogs: The invention provides novel derivatives of cyclopamine having the following formula:... Agent: Morrison & Foerster LLP

20090216023 - Novel indole derivatives as selective androgen receptor modulators (sarms): The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.... Agent: Philip S. Johnson Johnson & Johnson

20090216024 - Processes for making pioglitazone and compounds of the processes: Pioglitazone can be made via a Darzens Condensation reaction in an industrially useful process.... Agent: Synthon Ip Inc

20090209760 - Organometallic complexes as phosphorescent emitters in organic leds: Organic light emitting devices are described wherein the emissive layer comprises a host material containing an emissive molecule, which molecule is adapted to luminesce when a voltage is applied across the heterostructure, and the emissive molecule is selected from the group of phosphorescent organometallic complexes, including cyclometallated platinum, iridium and... Agent: Kenyon & Kenyon LLP

20090209761 - Photosensitizer dye: g

20090209762 - Photosensitizer dye:

20090209763 - Novel process for making bisphosphonic acids using diluents other than halogenated hydrocarbons: Provided is a novel method of making bisphosphonic acids, e.g. risedronic acid, including the step of combining a carboxylic acid, phosphorous acid, and a halophosphorous compound in the presence of a diluent that is an aromatic hydrocarbon or a silicone fluid. When the diluent is an aromatic hydrocarbon, an inert... Agent: Kenyon & Kenyon LLP

20090209764 - Process for preparation of 4-amino-1-isobutyl-1h-imidazo[4,5-c]-quinoline (imiquimod): A process for the preparation of imiquimod comprising oxidation of 1-Isobutyl-1H-imidazo quinoline quinoline (II) afforded 1-Isobutyl-1H-imidazo-[4,5-c]-quinoline-5-N-oxide (III) which is isolated in pure form as its hydrochloride salt (IV) followed by conversion to 4-chloro derivative (V) and conversion to corresponding 4-iodo derivative (VI) which is a new intermediate. This new intermediate... Agent: Pharmaceutical Patent Attorneys, LLC

20090209765 - Process for production of 4-fluoroisoquinoline-5-sulfonyl halide or salt thereof: The process for producing 4-fluoroisoquinoline-5-sulfonyl halide or a salt thereof, characterized in that the process includes reacting 4-fluoroisoquinoline or a salt thereof with sulfuric anhydride in the presence or absence of sulfuric acid, to thereby form 4-fluoroisoquinoline-5-sulfonic acid or a salt thereof, and, subsequently, reacting the formed sulfonic acid compound... Agent: Oblon, Spivak, Mcclelland Maier & Neustadt, P.C.

20090209766 - Process for the preparation of 4-amino-2,2,6,6-tetramethylpiperidine: 4-amino-2,2,6,6-tetramethylpiperidine is prepared by reacting 2,2,6,6-tetramethylpiperidine-4-one with ammonia and hydrogen in the presence of nickel and/or cobalt catalyst and water. The main reaction is carried out at a pressure of at most 50 bar and a temperature of at most 120° C. up to a conversion of the 2,2,6,6-tetramethylpiperidine-4-one of... Agent: Oblon, Spivak, Mcclelland Maier & Neustadt, P.C.

20090209767 - 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound: a

20090203911 - Benzimidazole compound: where R1 and R3 may be the same or different and each represent a hydrogen atom or a C1-C6 alkyl group; R2 represents (5,5-dimethyl-1,3-dioxan-2-yl)methoxy group, 5,7-dioxaspiro[2.5]oct-6-ylmethoxy group, 1,5,9-trioxaspiro[5.5]undec-3-ylmethoxy group, or (2,2-dimethyl-1,3-dioxan-5-yl)methoxy group; R4, R5, R6 and R7 represent a hydrogen atom, halogen atom, C1-C6 alkyl group, C1-C6 haloalkyl group, C1-C6... Agent: Birch Stewart Kolasch & Birch

20090203912 - Regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles: wherein R0; R1; R2; R3; R4; R5; A1; A2; A3; A4, Q and J have the meanings indicated in the claims. The present invention provides a direct palladium catalyzed, regioselective process to a wide variety of unsymmetrical, multifunctional N-substituted benzimidazoles or azabenzimidazoles of formula I starting from 2-halo-nitroarenes and N-substituted... Agent: Andrea Q. Ryan Sanofi-aventis U.s. LLC

20090203913 - Asymmetric friedel-crafts alkylations catalyzed by bifunctional cinchona alkaloids: In certain embodiments, the present invention relates to methods for asymmetric Friedel-Crafts alkylation catalyzed by bifunctional cinchona alkaloids. In certain embodiments, the catalyst is a 6′-OH cinchona alkaloid. In certain embodiments, the electrophile is an α-ketoester or aldehyde. In certain embodiments, the nucleophile is an aromatic heterocycle. In certain embodiments,... Agent: Foley Hoag, LLP Patent Group, World Trade Center West

20090203914 - Process for the preparation of solifenacin: A process for the preparation of (1S)-QR)-I -azabicyclo[2.2.2.]oct-3-yl 3,4-dihydro-1-phenyl- 2(1H)-isoquino-line carboxylate by reacting (1S)-alkyl 1-phenyl-1,2,3,4-tetrahydro-2-isoquinoline carboxylate with 3-(R)-quinuclidol in an inert solvent, where a primary alkyl ester of the carboxylate whose alkyl length is C1-C4 is used and the reaction is catalyzed by a non-nu-cleophilic base.... Agent: Pearl Cohen Zedek Latzer, LLP

20090203915 - Process for the preparation of solifenacin: p

20090203916 - Amorphous object of cinnamide compound: An amorphous object of (3E)-1-[l(s)-1-(4-fluorophenyl)ethyl]-3-[3-methoxy-4-(4methyl-1H-imidazol-1-yl)benzylidene]piperidine-2-one, which is represented by the formula (1) and has Aβ-production inhibitory activity. The amorphous object has such satisfactory properties that it has excellent solubility, is stable, does not readily become a crystalline form, and has low hygroscopicity. It is hence suitable for use in pharmaceutical... Agent: Birch Stewart Kolasch & Birch

20090203911 - Benzimidazole compound: where R1 and R3 may be the same or different and each represent a hydrogen atom or a C1-C6 alkyl group; R2 represents (5,5-dimethyl-1,3-dioxan-2-yl)methoxy group, 5,7-dioxaspiro[2.5]oct-6-ylmethoxy group, 1,5,9-trioxaspiro[5.5]undec-3-ylmethoxy group, or (2,2-dimethyl-1,3-dioxan-5-yl)methoxy group; R4, R5, R6 and R7 represent a hydrogen atom, halogen atom, C1-C6 alkyl group, C1-C6 haloalkyl group, C1-C6... Agent: Birch Stewart Kolasch & Birch

20090203912 - Regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles: wherein R0; R1; R2; R3; R4; R5; A1; A2; A3; A4, Q and J have the meanings indicated in the claims. The present invention provides a direct palladium catalyzed, regioselective process to a wide variety of unsymmetrical, multifunctional N-substituted benzimidazoles or azabenzimidazoles of formula I starting from 2-halo-nitroarenes and N-substituted... Agent: Andrea Q. Ryan Sanofi-aventis U.s. LLC

20090203913 - Asymmetric friedel-crafts alkylations catalyzed by bifunctional cinchona alkaloids: In certain embodiments, the present invention relates to methods for asymmetric Friedel-Crafts alkylation catalyzed by bifunctional cinchona alkaloids. In certain embodiments, the catalyst is a 6′-OH cinchona alkaloid. In certain embodiments, the electrophile is an α-ketoester or aldehyde. In certain embodiments, the nucleophile is an aromatic heterocycle. In certain embodiments,... Agent: Foley Hoag, LLP Patent Group, World Trade Center West

20090203914 - Process for the preparation of solifenacin: A process for the preparation of (1S)-QR)-I -azabicyclo[2.2.2.]oct-3-yl 3,4-dihydro-1-phenyl- 2(1H)-isoquino-line carboxylate by reacting (1S)-alkyl 1-phenyl-1,2,3,4-tetrahydro-2-isoquinoline carboxylate with 3-(R)-quinuclidol in an inert solvent, where a primary alkyl ester of the carboxylate whose alkyl length is C1-C4 is used and the reaction is catalyzed by a non-nu-cleophilic base.... Agent: Pearl Cohen Zedek Latzer, LLP

20090203915 - Process for the preparation of solifenacin: p

20090203916 - Amorphous object of cinnamide compound: An amorphous object of (3E)-1-[l(s)-1-(4-fluorophenyl)ethyl]-3-[3-methoxy-4-(4methyl-1H-imidazol-1-yl)benzylidene]piperidine-2-one, which is represented by the formula (1) and has Aβ-production inhibitory activity. The amorphous object has such satisfactory properties that it has excellent solubility, is stable, does not readily become a crystalline form, and has low hygroscopicity. It is hence suitable for use in pharmaceutical... Agent: Birch Stewart Kolasch & Birch

20090198061 - Camptothecin analogs and methods of preparation thereof: P

20090198062 - Novel process: The present invention relates to a process for the preparation of bisphosphonic acids and salts thereof, in particular monosodium salts thereof. The invention also relates to the conversion of the bisphosphonic acids to their sodium salts using an aqueous-organic solvent system. The present invention further relates to the conversion of... Agent: Dorsey & Whitney, LLP Intellectual Property Department

20090198063 - Novel heterocyclic compound or salt thereof and intermediate thereof: Disclosed is a compound represented by the general formula: [wherein R1 represents an aryl or heterocyclic group which may be substituted or the like; X1 represents a C2-C4 alkylene group or the like; X2, X3 and X5 independently represent NH, a bond or the like; X4 represents a lower alkylene... Agent: Oblon, Spivak, Mcclelland Maier & Neustadt, P.C.

20090198064 - Process for preparing quinuclidinium carbamate derivatives: s

20090198065 - Resist polymer, resist composition, process for pattern formation, and starting compounds for production of the resist polymer: In formulas (1) and (2), n represents an integer of 2 to 24; J represents a single bond or a divalent hydrocarbon group which may have a substituent/heteroatom when n=2, or represents an n-valent hydrocarbon group which may have a substituent/heteroatom when n≧3; E represents a residue of a polymerization... Agent: Oblon, Spivak, Mcclelland Maier & Neustadt, P.C.

20090198066 - Amorphous esomeprazole hydrate: The present invention relates to a novel amorphous form of esomeprazole hydrate, to a process for its preparation and to a pharmaceutical composition containing it. Thus, tetrahydrofuran and water are added to esomeprazole potassium salt at 25-30° C., cooled to 20° C. and then the pH is adjusted to 7.5-8.0... Agent: Caesar, Rivise, Bernstein, Cohen & Pokotilow, Ltd.

20090198067 - (1s,5s)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate: The present invention relates to the salt (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate and to methods of preparing the salt.... Agent: Paul D. Yasger Abbott Laboratories

20090198068 - Substance having antioxidant, geroprotective and anti-ischemic activity and method for the preparation thereof: The invention relates to the field of medicine, namely to new biologically active compounds, particularly to 2,4,6-trimethyl-3-hydroxypyridine derivatives and salts thereof (compound 1) having antioxidant, geroprotective and anti-ischemic action. The salts of compound (1) are prepared by reacting equimolecular quantities of 2,4,6-trimethyl-3-hydroxypyridine and dicarboxylic in solution of a lower alcohol... Agent: Kathryn A. Piffat, Ph.d. Edwards Angell Palmer & Dodge LLP